Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_assertion type Assertion NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_head.
- NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_provenance.
- NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_assertion evidence source_evidence_literature NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_provenance.
- NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_assertion SIO_000772 23861247 NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_provenance.
- NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_assertion wasDerivedFrom befree-20140225 NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_provenance.
- NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_assertion wasGeneratedBy ECO_0000203 NP295393.RAFezH6mPZpSvMpAzHqqIvt75gf_lkorUtpBKyn6g0eMs130_provenance.